OptiNose, Inc. Credit Agreements

6 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Fifth Waiver to Note Purchase Agreement among OptiNose US, Inc., OptiNose AS, OptiNose, Inc., Purchasers, and BioPharma Credit PLC (Nov. 9, 2022)
Waiver Agreements
OptiNose, Inc.
Pharmaceuticals
NY
2022
Third Amendment to Note Purchase Agreement among OptiNose US, Inc., OptiNose AS, OptiNose, Inc., Purchasers, and BioPharma Credit PLC
Note Agreements
OptiNose, Inc.
Pharmaceuticals
2022
Third Amendment to Note Purchase Agreement among Optinose US, Inc., Optinose AS, Optinose, Inc., Purchasers, and Biopharma Credit PLC
Modification Agreements
OptiNose, Inc.
Pharmaceuticals
2022
Second Amendment to Note Purchase Agreement among OptiNose US, Inc., OptiNose AS, OptiNose, Inc., OptiNose UK Limited, Purchasers, and BioPharma Credit PLC
Note Agreements
OptiNose, Inc.
Pharmaceuticals
2021
First Amendment to Note Purchase Agreement among Optinose US, Inc., Optinose AS, Optinose, Inc., Optinose UK Limited, Purchasers, and Biopharma Credit PLC
Note Agreements
OptiNose, Inc.
Pharmaceuticals
2021
Amendment to Note Purchase Agreement between OptiNose US, Inc. and BioPharma Credit PLC et al.
Note Agreements
OptiNose, Inc.
Pharmaceuticals
2020